source
- Merck's China-sourced ADC shows survival benefit in Phase 3 endometrial cancer trialMerck & Co., in partnership with Chinese biotech Kelun-Biotech, reported that its experimental antibody-drug conjugate sacituzumab tirumotecan (Sac-TMT) met its primary endpoint in a global Phase 3…
- FDA approves AstraZeneca’s baxdrostat for select hypertension patientsAstraZeneca announced that the U.S. Food and Drug Administration has granted approval for its blood‑pressure pill baxdrostat, targeting a specific group of patients with hypertension. The approval…